Obesity and related diseases are becoming more prevalent. Conjugated linoleic acid (CLA) might be a useful coadjutant treatment helping to decrease fat mass. However, the precise impact of CLA is unclear because the decreased body fat mass is followed by an increase in insulin resistance. This study aimed to evaluate some of the consequences of a high dose of CLA in rats fed a normal low fat or a high fat diet for 30 days. Male Wistar rats were separated into 4 groups (each n = 10): Control group receiving 7% fat (soybean oil); CLA group receiving 4% soybean oil and 3% CLA mixture; animal fat (AF) group, receiving 45% fat (lard); and animal fat plus CLA (AF+CLA) group, receiving 42% lard and 3% CLA mixture. The CLA mixture contained 39.32 mole% c9,t11-CLA and 40.50 mole% t10,c12-CLA. After 30 days, both CLA groups (CLA and AF+CLA groups) developed insulin resistance, with an increase in glucose in the fasting state and in an insulin tolerance test. The CLA group had increased liver weight and percentage of saturated fatty acids in liver and adipose tissue. Feeding the high fat diet resulted in increased hepatic triacylglycerol accumulation and this was exacerbated by dietary CLA. It is concluded that a high dose of CLA mixture increases insulin resistance and exacerbates hepatic steatosis when combined with a high fat diet. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 59 60 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 59 60
Obesity and related diseases are becoming more prevalent. Conjugated linoleic acid (CLA) might be a useful coadjutant treatment helping to decrease fat mass. However, the precise impact of CLA is unclear because the decreased body fat mass is followed by an increase in insulin resistance. This study aimed to evaluate some of the consequences of a high dose of CLA in rats fed a normal low fat or a high fat diet for 30 days. Male Wistar rats were separated into 4 groups (each n = 10): Control group receiving 7% fat (soybean oil); CLA group receiving 4% soybean oil and 3% CLA mixture; animal fat (AF) group, receiving 45% fat (lard); and animal fat plus CLA (AF+CLA) group, receiving 42% lard and 3% CLA mixture. The CLA mixture contained 39.32 mole% c9,t11-CLA and 40.50 mole% t10,c12-CLA. After 30 days, both CLA groups (CLA and AF+CLA groups) developed insulin resistance, with an increase in glucose in the fasting state and in an insulin tolerance test. The CLA group had increased liver weight and percentage of saturated fatty acids in liver and adipose tissue. Feeding the high fat diet resulted in increased hepatic triacylglycerol accumulation and this was exacerbated by dietary CLA. It is concluded that a high dose of CLA mixture increases insulin resistance and exacerbates hepatic steatosis when combined with a high fat diet. 
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Obesity and related diseases are becoming more prevalent. Conjugated linoleic acid (CLA) might be a useful coadjutant treatment helping to decrease fat mass. However, the precise impact of CLA is unclear because the decreased body fat mass is followed by an increase in insulin resistance. This study aimed to evaluate some of the consequences of a high dose of CLA in rats fed a normal low fat or a high fat diet for 30
days. Male Wistar rats were separated into 4 groups (each n = 10): Control group receiving 7% fat (soybean oil); CLA group receiving 4% soybean oil and 3% CLA mixture; animal fat (AF) group, receiving 45% fat (lard); and animal fat plus CLA 
Introduction
Overweight and obesity were estimated to affect 33% of the world's adult population in 2005 and projections to 2030 indicate that the prevalence will reach over 55% of men and women aged 20 years or more [1] . A decrease in average life expectancy and increased risk of chronic diseases, such as type 2 diabetes, fatty liver disease, cardiovascular diseases and several cancers, are some of the adverse consequences associated with obesity [2] . Rats and mice fed a high animal fat diet have proved to be a useful animal model of obesity and metabolic syndrome as they develop obesity, insulin resistance and hepatic steatosis [3] .
Conjugated linoleic acid (CLA) refers to a class of conjugated dieonic isomers of linoleic acid [4] . Naturally occurring CLA isomers are present in ruminant fat and dairy products; c9,t11 CLA is one of the main CLA isomers in ruminant products (5) . It is produced in the rumen as a result of microbial biohydrogenation of linoleic and linolenic acids [5] . CLA isomers may also be produced by partial hydrogenation of vegetable oils; t10,c12 CLA is an example of such an industrially produced CLA [5] . CLA used in supplements originates from processing of vegetable oils, like sunflower oil, and is usually an equimolar mixture of c9,t11 and t10,c12 CLA. CLA has emerged as a possible adjuvant treatment for obesity because some studies show that it can increase lean mass and decrease fat mass in mice [6] and can induce apoptosis in preadipocytes [7] . Studies in mice have shown a reduction in body fat with enhanced lean mass after including a mix of the two isomers in the diet [8] [9] [10] . However, these two isomers seem to have different effects from one-another as revealed in studies in which they have been administered separately (6) . The t10,c12 appears to be the main CLA isomer able to decrease body fat mass, which occurs through diminished fatty acid uptake by adipocytes (7) . However this isomer also increases hepatic fatty acid synthase gene expression, and causes hepatomegaly and hyperinsulinemia [11] . [14] .
However, these changes in body composition are small and may not be clinically relevant [13] . Men with metabolic syndrome supplemented with t10,c12 CLA or with a CLA mixture for 4 weeks did not exhibit changes in body composition; nevertheless t10,c12 CLA caused an increase in insulin resistance, fasting glucose and plasma VLDL triacylglycerol [15] .
New strategies to treat obesity have been extensively studied. So far, there is no consensus on the recommended CLA dosage or isomer mixture that is effective, as noted in a recent review of Bejamin et al [16] , which reported doses ranging from 0.7 to 8 g/d. Therefore, considering the contradictory effects reported for CLA supplementation and the increasing incidence of obesity and related diseases, the present study aimed to investigate the effects of a CLA mixture in rats fed a low or a high fat diet. 
Materials and Methods

Animals
Biochemical Analyses
Total fat was extracted from 1 g of gastrocnemius muscle and 0.5 g of liver [18] . 
TAG and total cholesterol were assessed by commercial kits after lipid extraction (Labtest Diagnóstica S.A., Brazil, 87-2/100 and 76-2/100). For fatty acid analysis of liver and epididymal adipose tissue, fat was extracted by the same method cited above and fatty acids were methylated in a potassium hydroxide and methanol. Methyl esters were separated and identified on a gas chromatograph (Shimadzu Europe, Duisburg, Germany) equipped with an AOC-20i auto-injector (Shimadzu Europe, Duisburg, Germany) using a fused silica capillary column (Supelcowax, 30 m, 0.25 mm I.D., film thickness 0.25 µm). Helium was used as carrier gas and make-up gas was air.
Synthetic air was used for flame ionization detection at 250 °C. Injections were set in the split mode. Fatty acid methyl ester retention times were determined by comparison with external standards (Supelco 37 component FAME Mix; Supelco, Bellefonte, PA, USA) plus c9,t11-CLA and t10,c12-CLA isomers.
Serum lipid peroxidation was measured by the determination of thiobarbituric acid reactive species (TBARS) according to the method of Mihara and Uchiyama [19] .
Hepatic and serum reduced glutathione (GSH) was determined by the method of Sedlack and Lindsay [20] . The α-tocopherol concentration in serum and liver was 
Insulin Tolerance Test (ITT)
All animals were submitted to 5 to 6 hours fasting and were anesthetized with xylasin (0.6 µl/g weight) and ketamine (0.9 µl/g weight). After that, basal glucose was was assessed semi quantitatively and ranked as described by Kleiner et al [22] . The steatosis degree was associated with its morphological location. The number of adipocytes per histological field and the area of adipocytes were quantified. All histological analysis was done using a conventional light microscope.
Statistical Analysis
Data are expressed as mean ± standard deviation (SD). One-way analysis of variance (ANOVA) and Tukey post-test were used for data analysis using the GraphPad Prism version 5.00 for Windows (GraphPad Software, San Diego, CA, USA). Differences were considered significant when p < 0.05.
Results
After the experimental period, rats fed a high fat diet had an increase in body weight.
Although no significant differences were noted for food intake, the AF+CLA group consumed less CLA per kg of body weight compared to the CLA group due to differences in final body weight. Groups fed a high fat diet had increased body liver and 
adipose tissue weights compared to those fed the normal low fat diets (Table 1) . They also showed hepatocyte ballooning and presence of Mallory's corpuscles (Figure 1 ).
Inclusion of CLA in the normal low fat diet (CLA group) resulted in an increase in liver weight and decreased hepatic total cholesterol and generated an insulin resistant state, as shown by a decrease in the KITT, increase in fasting glucose and in area under the glycemic curve (Figure 2 ).
No differences were observed in the number of adipocytes per histological field or in adipocyte area among groups, as can be seen in Figure 1 . The high fat diet increased TAG accumulation in gastrocnemius muscle but decreased the muscular percentage contribution to body weight, enhanced hepatic total fat, TAG and α-tocopherol contents and increased serum lipid peroxidation, as shown in Table 1 .
The liver and epididymal adipose tissue fatty acid profiles are presented in Table 2 .
The groups that received the high fat diet had higher oleic acid content in the liver and epididymal fat, since this represents 42% of the fatty acids found in the lard. The CLA group showed higher hepatic and epididymal palmitic and stearic acids and lower oleic and linoleic acids, well as the higher hepatic docosahexaenoic acid, compared to the control group. The CLA group also showed the highest hepatic and epididymal palmitic acid and SFA and the lowest oleic acid and MUFA. AF+CLA group had lower hepatic stearic acid and epididymal linoleic acid than AF group. Increases in c9,t11 and t10,c12
isomers in the epididymal adipose tissue were linked with a decrease in linoleic acid, but the same was not observed in the liver.
Discussion
A high amount of a mixture of two CLA isomers added to either a normal fat diet or to a high animal fat diet increased fasting glucose, the area under the insulin curve and decreased the KITT, characterizing a state of insulin resistance. Furthermore, 3% [23] . However, Almeida et al. [24] described that 1.5% of a mixture of CLA did not change body composition, induce insulin resistance or increase serum HDL in rats receiving high fat diet. Malinska et al. [25] found that supplementation of 2% of a mixture of CLA protected against dyslipidemia, ectopic lipid deposition and insulin resistance in rats with hypertriacylglycerolmia receiving a high-carbohydrate diet.
Despite the reported effects of CLA to decrease body fat in animals [26] and arguable effects on body weight in humans [12, 13] , the present work did not report differences in adipose tissue weight, area of adipocytes and number of adipocytes per histological field with CLA feeding. However, the amount of the t10,c12 isomer present in adipose tissue was inversely associated with epididymal adipose tissue weight.
Clément et al. [11] described that C57Bl/6J mice fed 1% (by weight) of t10,c12 isomer had lower body fat, markedly fatty liver, hyperinsulinemia and higher hepatic gene expression of fatty acid synthase, PPARγ and SREBP1a. Both c9,t101 and t10,c12
isomers were able to activate PPARα, γ and β/δ [11] . Those authors hypothesized that hyperinsulinemia induces hepatic lipogenesis and higher fat uptake, resulting in hepatic steatosis. On the other hand, in adipocytes t10,c12 CLA seems to decrease the activation of PPARγ and consequently deceased glucose uptake and TAG synthesis [27] leading to an insulin resistant state. Furthermore, Poirier et al. [28] showed an induction of suppressors of cytokine signalling 3 (SOCS3) mRNA in adipocytes after 24 h incubation with t10,c12 CLA. SOCS3 can bind the insulin receptor and inhibit its autophosphorylation and insulin receptor subtract 1 (IRS-1) phosphorylation decreasing insulin action [29] . IL-6 induces SOC3 protein in hepatocytes [29] and increases its mRNA in preadipocytes [28] showing inflammation as a causal factor of insulin resistance. Older C57Bl/6J mice fed 0.5% t10,c12 CLA for 6 months showed lower body weight, body fat mass, and visceral fat mass and increased muscle weight and serum NEFA [6] . Furthermore, t10,c12 CLA and a mix of c9,t11 and t10,c12 CLA increased fasting glucose and insulin and decreased leptin. On the other hand, c9,t11
CLA was able to decrease glucose, insulin and NEFA. The study concluded that t10,c12 CLA is the isomer responsible for decreased body fat mass [6] . Concomitant to a reduction in body fat, t10,c12 CLA decreases serum leptin in mice [11] . It seems that the first alteration produced by t10,c12 CLA in mice is the increased gene expression of TNF-α and IL-6 in adipose tissue followed by a decrease in gene expression of leptin and adiponectin then a decrease in body fat [28] .
The response to CLA in changes in body weight, hepatic fat accumulation and induction of PPAR responsive genes seems to be different among species [30] . Mice are more sensitive to hepatic acyl-CoA oxidase gene induction and hepatic lipid accumulation than rats [30] . Furthermore, a high fat diet seems to worsen the effects of t10,c12 CLA, as shown in female rats fed a high fat diet [31] and a normal fat diet [32] enriched with CLA. In the present study, the normal fat diet supplemented with CLA developed insulin resistance without an increase in body weight. However, no changes were observed in the amount of hepatic fat or muscle fat. Although the CLA group did no show increased hepatic steatosis, they had an increase in the percentage of liver weight in relation to body weight, suggesting some damage to the liver. In addition to that, CLA isomers c9, t11 and t10, c12 seem to have different effects when 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 60
supplemented separately. A mixture of 1% CLA containing c9, t11CLA in higher amount than t10,c12 CLA exhibited benefits on lipid metabolism, resulting in lower fat deposition due to up regulation of protein and mRNA levels of PPARα, acyl CoA oxidase and uncoupling protein in mice [33] . Another study showed a reduction in fasting glucose, insulin and TAG and down regulation of inflammatory markers in adipose tissue of mice fed 0.58% c9, t101 CLA [34] .
CLA isomers were better incorporated in the group fed a normal fat diet compared to the high animal fat diet. Furthermore, the CLA group presented greater concentration of palmitic acid and stearic acid and lower levels of oleic acid. Another mechanism that may be involved in insulin resistance is the increase in palmitic acid content found in liver and adipose tissue. Adipocytes incubated with t10,c12 CLA showed a dosedependent decrease in stearoyl-CoA desaturase (SCD) mRNA and protein levels and lower levels of palmitoleic acid and oleic acid, indicating lower activity of this enzyme [35] . The drop in SCD seems to be responsible for the lower adipocyte differentiation and enhanced smaller adipocytes observed after t10,c12 CLA treatment [35] .
Moreover, the decrease in SCD activity can decrease the amount of cholesterol exported by the liver due to lower availability of oleic acid or other fatty acids [36] . The CLA group presented lower levels of serum and hepatic total cholesterol, which is consistent with the lower levels of oleic acid and enhanced percentage of palmitic acid and stearic acid presented by this group indicating a possible reduction in SCD. SCD knockout mice presented lower concentrations of hepatic TAG and cholesteryl ester and a pronounced decrease in hepatic MUFAs and increase in SFAs [37] . The CLA group had a lower amount of omega-6 fatty acids, linoleic acid was lower, which seems to allow the enzymes used to elongate and desaturase essential fatty acids to mildly increase the percentage of hepatic docosahexaenoic acid. Male Sprague-Dawley rats fed diets with 1, 3 and 5% of CLA also presented an increase in the hepatic percentage of omega-3 fatty acid [38] . 
Lipid peroxidation was increased in AF group as showed by serum TBARS. CLA supplementation decreased serum TBARS in AF+CLA group, however, serum α-tocopherol was also lower, suggesting that it may be consumed to decrease lipid peroxidation. Although the present study did not find changes in serum and hepatic GSH, c9, t11 CLA seems to improve the antioxidant profile when associated with highfat diet with an increase in GSH and activity of antioxidants enzymes, indicating better mitochondrial function [33] .
In the present study, male rats treated for 30 days with a CLA mixture had increased fasting glucose, the area under the curve of insulin and decreased KITT; in the high animal fat group hepatic CLA mix increased hepatic TAG and in the normal fat group CLA mix increased the percentage of SFAs in liver and epididymal adipose tissue. The present work reports the effects of a high dose of a commercially available CLA mix in rats fed a normal fat diet and a high fat diet. It is important to state that the dose of CLA used is much higher than what would be consumed by humans as a nutritional supplement. Furthermore, there is a possibility that the CLA mix contains other metabolically active isomers with unknown metabolic effects [39] .
Nevertheless, the main effects reported in the present study are supported by those of several other published studies and serve to focus attention on the consumption of CLA mix as a nutritional supplement. High dose of CLA mix generated insulin resistance comparable to the effects of a high fat diet and changed the hepatic and adipose tissue fatty acid profile.
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